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Materials and Methods 
 
All chemicals and reagents, unless otherwise stated, were purchased from chemical 
suppliers (Sigma-Aldrich, Fischer Scientific, Combi-Blocks) and used without purification. 
Silica gel chromatography purifications were carried out using AMD Silica Gel 60, 230-400 
mesh. 
1
H and 
13
C NMR spectra were recorded on a Bruker Prodigy 400 MHz instrument and are 
internally referenced to the residual solvent peak (chloroform). Data for 
1
H NMR are reported in 
the conventional form: chemical shift (δ ppm), integration, multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet), coupling constant (Hz). Data for 
13
C are reported in terms 
of chemical shift (δ ppm). High-resolution mass spectra were obtained with a JEOL JMS-600H 
High Resolution Mass Spectrometer at the California Institute of Technology Mass Spectral 
Facility. Sonication was performed using a Qsonica Q500 sonicator. Chemical reactions were 
monitored using thin layer chromatography (Merck 60 silica gel plates) and a UV-lamp for 
visualization.   
 
Plasmid pET22b was used as a cloning vector, cloning was performed using Gibson 
assembly.
1
 Cells were grown using Luria-Bertani medium or HyperBroth (AthenaES) with 100 
µg/mL ampicillin (LBamp or HBamp). Primer sequences are available upon request. 
Electrocompetent Escherichia coli cells were prepared following the protocol of Sambrook et 
al.
2
 T5 exonuclease, Phusion polymerase, and Taq ligase were purchased from New England 
Biolabs (NEB, Ipswich, MA). M9-N minimal medium (pH 7.4) was used as a buffering system 
for whole cells. Unless otherwise specified, M9-N minimal medium was used without a carbon 
source, and contains 47.7 mM Na2HPO4, 22.0 mM KH2PO4, 8.6 mM NaCl, 2.0 mM MgSO4, and 
0.1 mM CaCl2. 
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General Procedures  
Cloning plasmids and library generation. A codon-optimized gBlock of B. subtilis 
truncated globin (UniProt ID: O31607)
3
 was ordered from Integrated DNA Technologies (IDT) 
and used for library construction and reaction testing. The pET22b plasmid was used as a cloning 
vector. Site-saturation mutagenesis was performed using primers bearing the desired mutations 
using degenerate codons (NDT, VHG, TGG) ordered from IDT and used per the company’s 
instructions. Generated sequences were sequenced by Laragen using primers specific to the T7 
promotor. Unless noted otherwise, E. cloni
®
 Express BL-21 (DE3) cells were used for cloning. 
The other two strains used in these sets of experiments were the OverXpress™ C41 (DE3) and 
OverXpress™ C43 (DE3) lines (all from Lucigen). Electroporation was carried out in 2 mm 
electroporation cuvettes using the Gene Pulser XCell Electroporation System (Bio-Rad).  
Hemochrome assay. At room temperature, 1.75 mL pyridine was combined with 0.75 mL 
of 1M NaOH. The solution was vortexed for 30 seconds to ensure complete mixing then 
centrifuged for 1 minute at 5000 rpm to remove excess base from the pyridine solution. 0.75 mL 
of protein lysate in M9-N minimal medium was combined with 0.25 mL of the pyridine solution 
along with about 2.0 mg of sodium dithionite, the cuvette’s contents were mixed with a pipet and 
sealed with parafilm. The content’s absorbance was immediately read. The protein concentration 
was determined using an extinction coefficient of 196 mM
-1
 cm
-1
 at 420 nm. Baseline absorbance 
was determined through extrapolation of two points on either side of the hemochrome peak at 
390 and 450 nm.  
Growth and induction in flasks. Overnight cultures were prepared in LBamp medium (100 
µg/mL ampicillin) from glycerol stocks of B. subtilis truncated globin variants. The overnight 
cultures were incubated at 37 °C for 12 hours. Flasks containing HBamp medium (100 µg/mL 
ampicillin) were inoculated with 1% volume of the overnight culture. Flasks were incubated at 
37 °C until they reached OD600=0.6-0.8. Flasks were cooled on ice for 20 minutes, then induced 
with 0.5 mM final concentration isopropyl β-D-1-thiogalactopyranoside (IPTG) and 1 mM final 
concentration 5-aminolevulinic acid (ALA). Flasks were incubated at 25 °C for 18-24 hours. 
Cells were harvested via centrifugation at 4000 rpm, 10 minutes, at 4 °C.  
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Small-scale biocatalytic reactions. Small-scale (400 µL) reactions took place in 2 mL 
glass crimp vials. Whole cells expressing the enzyme were resuspended in M9-N minimal 
medium to the OD600 specified in the reaction conditions. The headspace of the vials was purged 
during gas cycling of an anaerobic chamber. The open vials were allowed to shake in the 
anaerobic chamber for one minute before reagents were added. 10 µL of 3,4-difluorostyrene 
(DFS, either 800 mM or 2 M in ethanol) was added to the reactions followed by 10 µL of ethyl 
diazoacetate (EDA, either 1.6 M or 4 M in ethanol). Vials were crimp-sealed with silicone septa 
and removed from the anaerobic chamber and allowed to shake at 400 rpm at room temperature 
for 1 hour. After reaction completion, reactions to be screened with gas chromatography (GC) 
had 0.9 mL cyclohexane and 20 µL acetophenone (40 mM in cyclohexane) added to them. The 
vials were vortexed for 30 seconds two times and then centrifuged at 13000 rpm for 5 minutes at 
20 °C. The supernatant was transferred to a clean 2 mL glass vial for analysis by GC. Reactions 
to be screened via supercritical fluid chromatography (SFC) had 0.9 ml of cyclohexane added to 
them then were vortexed twice for 30 seconds and centrifuged at 13000 rpm for 5 minutes at 20 
°C. The supernatant was moved to a clean 2 mL glass vial for analysis on the SFC. 
Enantioselectivity was screened using SFC, while yield and diastereoselectivity were determined 
by GC. All reactions were performed in triplicate (unless otherwise noted).  
Reaction screening in 96-well plates. Using sterile toothpicks, colonies were picked from 
site-saturation libraries on agar plates and used to inoculate a 96-well deep-well plate containing 
400 μL	of LBamp media per well. The cultures were incubated at 37 
o
C overnight at 180 rpm and 
80% relative humidity. After overnight growth, 30 µL of overnight culture was transferred to 1 
mL of HBamp media in a fresh 96-well deep-well plate using a multichannel pipette. The plates 
were incubated at 37 
o
C, 180 rpm, 80% relative humidity for 3 hours. The plates were then 
removed from the incubator and put on ice for 20 minutes. 3 µL of 1 M IPTG and 3 µL of 1 M 
ALA were added to the 96-well plate using a multichannel pipette. The plates were then 
incubated at 25 
o
C and 180 rpm for 18 hours. Cells were harvested by centrifugation at 4000 
rpm, 4 °C for 10 minutes and resuspended in 350 µL M9-N minimal media. In the anaerobic 
chamber 50 µL of DFS (0.16 M in ethanol) and EDA (0.32 M in ethanol) were added to the 
whole cells in each well. The plate was sealed with a gas-impermeable membrane and allowed to 
shake in the anaerobic chamber at room temperature at 400 rpm for 1 hour. The plate was then 
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removed from the anaerobic chamber, and 1 mL of cyclohexane was added to each well using a 
multichannel pipette and mixed up and down three times. The plates were spun for 5 minutes at 
4000 rpm and 20 
o
C to separate the organic and aqueous layers. 600 µL of the organic layer was 
transferred into a shallow 96-well plate and screened for enantioselectivity on the SFC.  
Large-scale biocatalytic reactions  
One-pot preparative scale reactions. 19 mL of OD600=80 whole-cell catalyst, 
resuspended in M9-N minimal medium, was added to a clean 100 mL round bottomed flask. The 
flask was then sealed with a rubber stopper, covered with parafilm, and the headspace was 
purged with argon for 10 minutes while the cell mixture was stirred with a 1 cm stir bar at ~100 
rpm. The headspaces of a solution of DFS (800 mM in ethanol) and a solution of EDA (1.6 M in 
ethanol) were purged under argon for 2 minutes. The flask was placed on a stir plate and set to 
~100 rpm. 0.5 mL of the DFS solution was added dropwise to the flask through a syringe over a 
period of ~1 minute. Then 0.5 mL of the EDA solution was added dropwise through a syringe 
into the flask over a period of ~1 minute. The reaction was allowed to stir for 15 hours at room 
temperature, after which the reaction was worked up according to procedure described below.  
Reactions using slow addition of catalyst and EDA. An empty 100 mL round bottomed 
flask with a 1 cm stir bar sealed with a rubber stopper and parafilm was purged with argon for 10 
minutes. 19 mL of OD600=80 whole-cell catalyst resuspended in M9-N minimal medium was 
added to a 50 mL conical tube. The head space of the 50 mL conical tube was purged with argon 
for 10 minutes. The headspaces of a solution of DFS (800 mM in ethanol) and a solution of EDA 
(1.6 M in ethanol) were purged under argon for 2 minutes. 0.5 mL of the DFS solution was 
added to the flask. The flask was put onto a stir plate and set to ~100 rpm. 0.5 mL of EDA 
solution and 19 mL of whole cell-catalyst solution were loaded into separate syringes. Over the 
next 3 hours the EDA solution was added to the flask at a rate of 0.17 mL/hr, and the cell 
solution was added at a rate of 6.3 ml/hr to the flask containing the DFS using a syringe pump. 
The reaction was allowed to continue for 12 hours past the final addition of either catalyst or 
EDA for a total reaction time of 15 hours at room temperature. The reaction was worked up 
according to procedure described below. 
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Workup of large-scale reactions. The 20 mL reaction was poured into a falcon tube. 20 
mL of cyclohexane was added to falcon tube. The tube was vortexed for 30 seconds two times 
and then spun at 5000 rpm and 20 °C for 30 minutes. 1 mL of the cyclohexane supernatant was 
removed for enantioselectivity analysis on the SFC. 377 µL of acetophenone (40 mM in 
cyclohexane) was added to the remainder of the reaction mixture, the mixture was again 
vortexed for 30 seconds two times and then spun at 5000 rpm 20 °C for 15 minutes. The 
supernatant was analyzed for yield and diastereoselectivity on the GC.  
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Chemical Synthesis, Characterization and NMR Spectra of Cyclopropane 5  
 
 
 
Racemic ticagrelor cyclopropane rac-(5) was prepared according to the following 
procedure: To hemin (1.63 g, 2.5 mmol) in water (20 mL) under Ar was added 3,4-
difluorostyrene (1.72 g, 10 mmol). Ethyl diazoacetate (2.42 mL, 20 mmol) in DCM (3 mL) was 
added dropwise to the vigorously stirred mixture, and the reaction was left to stir for 12 h. The 
reaction was extracted with hexane (20 mL x 3), and the organic extracts were washed with brine 
(50 mL), dried (MgSO4) and concentrated in vacuo. Purification by silica flash chromatography 
(2 to 20% EtOAc in hexane) separated the desired trans-cyclopropane from its cis-isomer and 
gave rac-(5) as a colorless oil (1.43 g, 6.3 mmol, 63%).  
1
H NMR (400 MHz, CDCl3) δ 7.05 (1H, td, J = 10.3, 8.5 Hz, H11), 6.94–6.74 (2H, m, H8 and 
H12), 4.17 (2H, q, J = 7.2 Hz, H2), 2.47 (1H, ddd, J = 9.4, 6.4, 4.2 Hz, H6), 1.84 (1H, ddd, J = 
8.5, 5.3, 4.2 Hz, H4), 1.59 (1H, ddd, J = 9.2, 5.3, 4.8 Hz, H5a), 1.28 (3H, t, J = 7.1 Hz, H1), 1.24 
(1H, ddd, J = 8.4, 6.4, 4.8 Hz, H5b). 
 
13
C NMR (100 MHz, CDCl3) δ 173.1, 151.0 (dd, 
1
JC−F = 118.7 Hz, 
2
J C−F = 12.8 Hz), 148.6 (dd, 
1
JC−F = 117.5 Hz, 
2
J C−F = 12.7 Hz), 137.3 (dd, 
3
JC−F = 5.9 Hz, 
4
J C−F = 3.7 Hz), 122.5 (dd, 
3
JC−F = 
6.2 Hz, 
4
J C−F = 3.4 Hz), 117.3 (dd, 
2
JC−F = 17.2 Hz, 
3
J C−F = 0.2 Hz), 115.3 (d, 
2
JC−F = 17.6 Hz), 
61.0, 25.3 (d, 
4
JC−F = 1.7 Hz), 24.3, 17.1, 14.4. 
 
HRMS (FAB) m/z: 227.0904 (M+H
 +
); calc. for C12H13F2O2: 227.0884. 
 
[αD]
25
 = −213.7 (c 0.55 in EtOH, 98% ee) 
 
The absolution configuration of enzymatically synthesized cyclopropane (R,R)-5 was 
determined by comparing (1) the optical rotation value of (R,R)-5 and (2) the HPLC retention 
times of rac-5 and (R,R)-5 with that reported in the literature.
4
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1
H NMR (400 MHz, CDCl3) 
13
C NMR (100 MHz, CDCl3) 
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Gas Chromatography (GC) Method  
Gas chromatography analyses were carried out using a Shimadzu GC-17A gas chromatograph, a 
FID detector, and a J&W HP-5 column (30m x 0.32 mm, 0.25 m film). Acetophenone was used 
as an internal standard. The temperature program used is shown below: 
 
Rate (°C/min) Temp (°C) Hold Time (min) 
0 90 2 
6 150 0 
80 230 1 
Total GC method time: 14 minutes 
 
A representative example of a GC trace of cyclopropane 5, 3,4-difluorostyrene, and 
acetophenone is shown below:  
 
Peak Retention time (min) Identity 
1 2.51 Acetophenone 
2 4.09 3,4-difluorostyrene 
3 8.96 cis-isomer of cyclopropane 5 
4 9.92 cyclopropane 5 
4 3 2 
1 
 
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The GC standard curve for cyclopropane 5 is shown below: 
 
 
 
Sample preparation for GC standard curve. The GC standard curve was generated using 
known amounts of chemically synthesized racemic cyclopropane 5 and performing mock 
extraction on the same scale as the small-scale biocatalytic reactions. For the mock extractions, 
375 µL of M9-N minimal medium, 25 µL of cyclopropane 5 at various concentrations (5 to 400 
mM in cyclohexane), 0.9 mL of cyclohexane, and 20 µL of acetophenone (40 mM in 
cyclohexane) were mixed and vortexed for 30 seconds two times then spun at 14,000 rpm and 20 
°C for 5 minutes. The cyclohexane supernatant was transferred to 2 mL glass vials and quantified 
using the GC. The average of duplicate extractions was used for the GC standard curve. 
 
y = 0.9203x + 0.0578
R² = 0.9952
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Supercritical Fluid Chromatography (SFC) Method  
Analytical chiral supercritical fluid chromatography was performed with a JACSO 2000 series 
instrument using i-PrOH and supercritical CO2 as the mobile phase, with visualization at 210 and 
254 nm. The column used was AD-H (4.6 mm x 250 mm) from Chiral Technology.  
 
The SFC traces for racemic and enzymatically synthesized cyclopropane 5 are shown below. 
 
Chiralpak AD-H, 2% i-PrOH in CO2, 2.5 mL/min, 210 nm 
 
 
 
 
Area% report for rac-5 and (R,R)-5:  
rac-5 (R,R)-5 
Retention 
Time (min) 
Area 
(mAU*s) 
Area % 
Retention 
Time (min) 
Area 
(mAU*s) 
Area % 
3.768 17277.5 48.16 3.773 129.3 0.54 
4.377 18598.3 51.84 4.309 23713.4 99.46 
Total 35875.8 100.00 Total 23842.7 100.00 
 
 
 
 
(S,S)-5 (R,R)-5 
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Supporting Tables  
 
Table S1. Preliminary experiments with hemin or E. coli cells expressing various heme proteins  
 
 
 
  yield % 
dr 
(trans:cis) 
% ee 
(trans) 
Hemin (0.1 mM) 6 92:8 0 
Rhodothermus marinus cyt c M100D V75T
5
 6 91:9 −13 
Physeter macrocephalus Mb H64V V68A
6
 38 90:10 −93±3 
Hydrogenobacter thermophilis cyt c M59A 
Q62A
5
 
19±6 93:7 50±4 
BM3 Hstar heme
7
 82±6 94:6 10 
BM3 Hstar
7
 19 91:9 18 
BM3 Hstar H92N H100N
8
 26 92:8 38 
 
 
Reaction with hemin: A 1 mM solution of hemin was prepared in DMSO. 40 µL of 1 mM 
hemin solution was added to 340 µL of M9-N minimal medium. The reactions were performed at 
room temperature under anaerobic conditions with a final concentration of 10 mM DFS and 20 
mM EDA for 1 hour. The reaction was performed in duplicate.  
 
Whole-cell reactions: Cells were grown according to literature procedure (see references 
cited). Experiments were performed using whole-cell catalysts resuspended in M9-N minimal 
medium to OD600=60. The reactions were performed at room temperature under anaerobic 
conditions with a final concentration of 10 mM DFS and 20 mM EDA for 1 hour. Reactions 
were performed in duplicate.  
EtO2C
F
F
F
F
+ EtO2C N2
OD600=60 whole cell catalyst
M9-N buffer (pH 7.4), 10 mM DFS, 
20 mM EDA, room temperature, 1 hour
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Table S2. Background reactions of different strains of E. coli. 
 
 
 
 
  yield % 
dr 
(trans:cis)  
% ee 
(trans)  
BL 21 44.70 92:8 −5 
C 41
* 
34.84 93:7 −5 
C 43
* 
27.77 91:9 −8 
 
 
Cells with no pET22b plasmid were grown and induced according to procedure described in 
General Procedures using media with no antibiotics. Small-scale biocatalytic experiments were 
performed using whole-cell catalysts resuspended in M9-N minimal medium to OD600=60. The 
reactions were performed at room temperature under anaerobic conditions with a final 
concentration of 20 mM DFS and 40 mM EDA for 1 hour. Reactions were performed in 
duplicate.  
 
*
Lucigen’s C43(DE3) and C41(DE3) are derived from BL21(DE3) and have mutations in the 
lacUV5 promoter which lower the expression of T7RNA polymerase causing protein production 
to occur more slowly.
9
 It is unclear how this improves the expression of cytosolic proteins.  
EtO2C
F
F
F
F
+ EtO2C N2
OD600=60 whole cell catalyst
M9-N buffer (pH 7.4), 20 mM DFS, 
40 mM EDA, room temperature, 1 hour
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Nucleotide and Amino Acid Sequences  
 
B. subtilis truncated globin wild-type amino acid sequence  
MGQSFNAPYEAIGEELLSQLVDTFYERVASHPLLKPIFPSDLTETARKQKQFLTQYLGGP
PLYTEEHGHPMLRARHLPFPITNERADAWLSCMKDAMDHVGLEGEIREFLFGRLELTAR
HMVNQTEAEDRSS 
 
B. subtilis truncated globin wild-type nucleotide sequence  
ATGGGTCAAAGTTTCAATGCACCATACGAAGCCATCGGGGAAGAGCTGCTCAGTCA
GCTCGTTGATACGTTCTATGAACGTGTGGCGTCTCATCCGCTGCTCAAACCGATTTTT
CCGTCTGATCTGACGGAAACCGCACGTAAACAGAAGCAGTTTCTGACGCAATATCTC
GGTGGTCCGCCGTTATACACTGAAGAACATGGTCACCCAATGCTTCGCGCGCGGCAC
CTCCCATTCCCGATCACCAATGAGCGTGCGGACGCTTGGCTCTCCTGTATGAAAGAC
GCAATGGATCACGTGGGACTGGAAGGTGAAATTCG 
TGAATTCCTGTTTGGTCGTTTAGAACTGACGGCGCGCCACATGGTCAATCAGACCGA
AGCAGAAGACCGGAGCAGC 
 
B. subtilis truncated globin T45A Q49A amino acid sequence  
MGQSFNAPYEAIGEELLSQLVDTFYERVASHPLLKPIFPSDLTEAARKAKQFLTQYLGGP
PLYTEEHGHPMLRARHLPFPITNERADAWLSCMKDAMDHVGLEGEIREFLFGRLELTAR
HMVNQTEAEDRSS 
 
B. subtilis truncated globin T45A Q49A nucleotide sequence  
ATGGGTCAAAGTTTCAATGCACCATACGAAGCCATCGGGGAAGAGCTGCTCAGTCA
GCTCGTTGATACGTTCTATGAACGTGTGGCGTCTCATCCGCTGCTCAAACCGATTTTT
CCGTCTGATCTGACGGAAGCCGCACGTAAAGCGAAGCAGTTTCTGACGCAATATCTC
GGTGGTCCGCCGTTATACACTGAAGAACATGGTCACCCAATGCTTCGCGCGCGGCAC
CTCCCATTCCCGATCACCAATGAGCGTGCGGACGCTTGGCTCTCCTGTATGAAAGAC
GCAATGGATCACGTGGGACTGGAAGGTGAAATTCGTGAATTCCTGTTTGGTCGTTTA
GAACTGACGGCGCGCCACATGGTCAATCAGACCGAAGCAGAAGACCGGAGCAGC 
 
B. subtilis truncated globin Y25L T45A Q49A amino acid sequence  
MGQSFNAPYEAIGEELLSQLVDTFLERVASHPLLKPIFPSDLTEAARKAKQFLTQYLGGP
PLYTEEHGHPMLRARHLPFPITNERADAWLSCMKDAMDHVGLEGEIREFLFGRLELTAR
HMVNQTEAEDRSS 
 
B. subtilis truncated globin Y25L T45A Q49A nucleotide sequence  
ATGGGTCAAAGTTTCAATGCACCATACGAAGCCATCGGGGAAGAGCTGCTCAGTCA
GCTCGTTGATACGTTCCTGGAGCGTGTGGCGTCTCATCCGCTGCTCAAACCGATTTTT
CCGTCTGATCTGACGGAAGCCGCACGTAAAGCGAAGCAGTTTCTGACGCAATATCTC
GGTGGTCCGCCGTTATACACTGAAGAACATGGTCACCCAATGCTTCGCGCGCGGCAC
CTCCCATTCCCGATCACCAATGAGCGTGCGGACGCTTGGCTCTCCTGTATGAAAGAC
GCAATGGATCACGTGGGACTGGAAGGTGAAATTCGTGAATTCCTGTTTGGTCGTTTA
GAACTGACGGCGCGCCACATGGTCAATCAGACCGAAGCAGAAGACCGGAGCAGC 
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Alignment of P. macrocephalus Mb and B. subtilis TrHb  
 
The mutations found to improve cyclopropanation activity of P. macrocephalus Mb by Fasan et 
al.
6
 and their corresponding residues in B. subtilis TrHb are highlighted in red. Alignment was 
performed using the PROMALS3D web server,
10
 using PDB files 1UX8 and 1A6K. 
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